TOMM20 as a potential therapeutic target of colorectal cancer
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Translocase of outer mitochondrial membrane 20 (TOMM20) plays an essential role as a receptor for proteins targeted to mitochondria. TOMM20 was shown to be overexpressed in various cancers. However, the oncological function and therapeutic potential for TOMM20 in cancer remains largely unexplored. The purpose of this study was to elucidate the underlying molecular mechanism of TOMM20’s contribution to tumorigenesis and to explore the possibility of its therapeutic potential using colorectal cancer as a model. The results show that TOMM20 overexpression resulted in an increase in cell proliferation, migration, and invasion of colorectal cancer (CRC) cells, while siRNA-mediated inhibition of TOMM20 resulted in significant decreases in cell proliferation, migration, and invasion. TOMM20 expression directly impacted the mitochondrial function including ATP production and maintenance of membrane potential, which contributed to tumorigenic cellular activities including regulation of S phase cell cycle and apoptosis. TOMM20 was overexpressed in CRC compared to the normal tissues and increased expression of TOMM20 to be associated with malignant characteristics including a higher number of lymph nodes and perineural invasion in CRC. Notably, knockdown of TOMM20 in the xenograft mouse model resulted in a significant reduction of tumor growth. This is the first report demonstrating a relationship between TOMM20 and tumorigenesis in colorectal cancer and providing promising evidence for the potential for TOMM20 to serve as a new therapeutic target of colorectal cancer.
Abstract
Translocase of outer mitochondrial membrane 20 (TOMM20) plays an essential role as a receptor for proteins targeted to mitochondria. TOMM20 was shown to be overexpressed in various cancers. However, the oncological function and therapeutic potential for TOMM20 in cancer remains largely unexplored. The purpose of this study was to elucidate the underlying molecular mechanism of TOMM20’s contribution to tumorigenesis and to explore the possibility of its therapeutic potential using colorectal cancer as a model. The results show that TOMM20 overexpression resulted in an increase in cell proliferation, migration, and invasion of colorectal cancer (CRC) cells, while siRNA-mediated inhibition of TOMM20 resulted in significant decreases in cell proliferation, migration, and invasion. TOMM20 expression directly impacted the mitochondrial function including ATP production and maintenance of membrane potential, which contributed to tumorigenic cellular activities including regulation of S phase cell cycle and apoptosis. TOMM20 was overexpressed in CRC compared to the normal tissues and increased expression of TOMM20 to be associated with malignant characteristics including a higher number of lymph nodes and perineural invasion in CRC. Notably, knockdown of TOMM20 in the xenograft mouse model resulted in a significant reduction of tumor growth. This is the first report demonstrating a relationship between TOMM20 and tumorigenesis in colorectal cancer and providing promising evidence for the potential for TOMM20 to serve as a new therapeutic target of colorectal cancer.
참고문헌 (24)
- Siegel RL, "Cancer Statistics, 2017", CA Cancer J Clin, 67, pp.7~30 (2017)
- Devetzi M, "Death receptor 5(DR5)and a 5-gene apoptotic biomarker panel with significant differential diagnostic potential in colorectal cancer", Sci Rep, 6, pp.36532~ (2016)
- Tsouma A, "Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients", World J Gastroenterol, 16, pp.5965~5974 (2010)
- Sotgia F, "Mitochondrial metabolism in cancer metastasis : visualizing tumor cell mitochondria and the"reverse Warburg effect"in positive lymph node tissue", Cell Cycle, 11, pp.1445~1454 (2012)
- Birsoy K, "An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis", Cell, 162, pp.540~551 (2015)
- Wilde L, "Metabolic coupling and the Reverse Warburg Effect in cancer : Implications for novel biomarker and anticancer agent development", Semin Oncol, 44, pp.198~203 (2017)
- Schieber M, "ROS function in redox signaling and oxidative stress", Curr Biol, 24, pp.R453~R462 (2014)
- Chacinska A, "Importing mitochondrial proteins : machineries and mechanisms", Cell, 138, pp.628~644 (2009)
- Wise DR, "Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alphaketoglutarate to citrate to support cell growth and viability", Proc Natl Acad Sci U S A, 108, pp.19611~19616 (2011)
- Curry JM, "Cancer metabolism, stemness and tumor recurrence : MCT1and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer", Cell Cycle, 12, pp.1371~1384 (2013)
- Zhao Z, "Stromal-epithelial metabolic coupling in gastric cancer : stromal MCT4 and mitochondrial TOMM20 as poor prognostic factors", Eur J Surg Oncol, 40, pp.1361~1368 (2014)
- Curry JM, "Multicompartment metabolism in papillary thyroid cancer", Laryngoscope, 126, pp.2410~2418 (2016)
- Mikkilineni L, "Hodgkin lymphoma : A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment", Semin Oncol, 44, pp.218~225 (2017)
- Lee AR, "Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer", Onco Targets Ther, 9, pp.6885~6895 (2016)
- Caino MC, "PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion", Proc Natl Acad Sci U S A, 112, pp.8638~8643 (2015)
- Rivadeneira DB, "Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion", Sci Signal, 8 (2015)
- Porporato PE, "A mitochondrial switch promotes tumor metastasis", Cell Rep, 8, pp.754~766 (2014)
- Sciacovelli M, "Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition", Nature, 537, pp.544~547 (2016)
- Wang C, "Elevated level of mitochondrial reactive oxygen species via fatty acid betaoxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition", Stem Cell Res Ther, 10, pp.175~ (2019)
- Li Y, "Biochanin A Induces S Phase Arrest and Apoptosis in Lung Cancer Cells", Biomed Res Int, 2018, pp.3545376~ (2018)
- Zhang J, "Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest", J Exp Clin Cancer Res, 36, pp.147~ (2017)
- Li MX, "Mitochondria and apoptosis : emerging concepts", F1000Prime Rep, 7, pp.42~ (2015)
- Suzuki R, "Spatiotemporal quantification of subcellular ATP levels in a single HeLa cell during changes in morphology", Sci Rep, 5, pp.16874~ (2015)
- Chen GQ, "Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis", Cell Death Differ (2019)